Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C5aR antagonists

C5aR antagonists

US Patent 10660897 · Granted May 26, 2020

Estimated economic value: $256,271,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Parenterally administered immune enhancing drugs2025
Parenterally administered immune enhancing drugs2025
Amorphous and crystalline forms of IDO inhibitors2025